Ontology highlight
ABSTRACT: Background
Decreased cerebrospinal fluid (CSF) amyloid-? 1-40 (A?40) and amyloid-? 1-42 (A?42) and increased total and phosphorylated tau (t-tau, p-tau) concentrations have been described in cerebral amyloid angiopathy (CAA).Objective
Our aim was to analyze these biomarkers in patients with CAA-related inflammation (CAA-I).Methods
We prospectively recruited nine patients with acute phase CAA-I fulfilling Chung criteria. CSF was analyzed for t-tau, p-tau, A?42, and A?40. Data were compared to controls (n?=?14), patients with Alzheimer's disease (AD, n?=?42), CAA (n?=?10), and primary angiitis of the central nervous system (PACNS, n?=?3).Results
For the CAA-I group, statistically significant differences were: lower A?42 (p?=?0.00053) compared to the control group; lower t-tau (p?=?0.018), p-tau (p?< ?0.001), and A?40 (p?< ?0.001) compared to AD; lower A?42 (p?=?0.027) compared to CAA; lower A?42 (p?=?0.012) compared to PACNS. Nearly significantly lower A?40 (p?=?0.051) and higher t-tau (p?=?0.051) were seen in CAA-I compared to controls.Conclusion
CSF biomarkers profile similar to that of CAA was observed in CAA-I (with even lower levels of A?42 compared to CAA). Based on our findings, high p-tau seems more specific for AD, whereas low A?42 differentiates CAA-I from CAA, PACNS, and controls, and low A?40 differentiates CAA-I from AD.
SUBMITTER: Renard D
PROVIDER: S-EPMC6294577 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
Renard Dimitri D Wacongne Anne A Ayrignac Xavier X Charif Mahmoud M Fourcade Genevieve G Azakri Souhayla S Le Floch Anne A Bouly Stephane S Marelli Cecilia C Arquizan Caroline C Hirtz Christophe C Gabelle Audrey A Thouvenot Eric E Lehmann Sylvain S
Journal of Alzheimer's disease : JAD 20160101 3
<h4>Background</h4>Decreased cerebrospinal fluid (CSF) amyloid-β 1-40 (Aβ40) and amyloid-β 1-42 (Aβ42) and increased total and phosphorylated tau (t-tau, p-tau) concentrations have been described in cerebral amyloid angiopathy (CAA).<h4>Objective</h4>Our aim was to analyze these biomarkers in patients with CAA-related inflammation (CAA-I).<h4>Methods</h4>We prospectively recruited nine patients with acute phase CAA-I fulfilling Chung criteria. CSF was analyzed for t-tau, p-tau, Aβ42, and Aβ40. D ...[more]